Cytokinetics to Host Virtual Investor & Analyst Day on July 15, 2020
SOUTH SAN FRANCISCO, Calif., July 01, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK), today announced that it will host […]
Arena Minerals Postpones the Release of its Interim Q1 Financial Results Due to COVID-19 Related Delays
TORONTO, July 01, 2020 (GLOBE NEWSWIRE) — ARENA MINERALS INC. (TSX.V:AN) (“Arena Minerals”, “Arena” or the “Company”), a junior mining […]
Syneos Health Schedules Second Quarter 2020 Earnings Call for Thursday, August 6, 2020
MORRISVILLE, N.C., July 01, 2020 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release […]
KellyOCG® Honors Supplier Excellence Award Winners
TROY, Mich., July 01, 2020 (GLOBE NEWSWIRE) — KellyOCG®, the outsourcing and consulting group of Kelly, has announced the recipients […]
Precipio Regains Listing Compliance with NASDAQ Minimum Bid Requirement
NEW HAVEN, Conn., July 01, 2020 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has […]
Middlesex Water Company Named a Top New Jersey Workplace
ISELIN, N.J., July 01, 2020 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ: MSEX), a provider of water, wastewater and related […]
Sorrento Announces Selection of T-VIVA-19™ as Targeted Protein Vaccine Candidate for SARS-CoV-2
T-VIVA-19 (targeted virus vaccine against COVID-19) is a recombinant fusion protein of the SARS-CoV-2 spike protein S1 domain and human […]
Aspira Women’s Health Inc. Announces Equity Financing of Approximately $11 Million
AUSTIN, Texas, July 01, 2020 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (Nasdaq: AWH) (“ASPIRA”), a bioanalytical-based women’s health company […]
Borqs Technologies missed the filing deadline for the 2019 Annual Report on Form 20-F and announced preliminary unaudited financial results
SANTA CLARA, Calif., July 01, 2020 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS), (the “Company”, or “Borqs”), a global […]
Esperion Announces Publication in the Journal of the American Medical Association Cardiology of Pooled Efficacy Analysis from the Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL® (bempedoic acid) Tablets
ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that pooled efficacy analysis from the […]
